News

Publication of clinical trial results evaluating TH-001 (PreDiaWell®) in Digital Health We are pleased to announce the publication of the […]

PreDiaWell® Achieves ORCHA Certification with an Outstanding 95% Score We are delighted to announce that PreDiaWell® has successfully passed ORCHA

Tesu Health to Present Clinical Trial Results at ATTD 2025 Tesu Health is pleased to announce its participation in the

Positive Topline Results from the TH001_1001 Clinical Trial Evaluating PreDiaWell® in Adults with Prediabetes We are pleased to announce positive

Tesu Health at Diabetes Professional Care 2024 On 15-16 October 2024, Tesu Health proudly attended Diabetes Professional Care (DPC) at

Patient Enrolment Completed in TH001_1001 Tesu Health is pleased to announce the completion of patient enrolment in the clinical trial

Tesu Health at Cambridge Tech Week 2024 From 9 to 13 September 2024, Cambridge Tech Week brought together some of

Announcing our seed funding round! TESU HEALTH RAISES SEED INVESTMENT AT A $2.5M VALUATION TO FURTHER ITS MISSION OF TRANSFORMING

Tesu Health Joins Cambridge Life Sciences Market Access Programme Tesu Health has been chosen as one of the ten companies

Two New R&D Projects in Chronic Diseases Tesu Health, today announced that two of its research and development projects have